... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Kidney transplantation Prostatectomy Prostatic adenocarcinoma Prostatic carcinoma Radical prostatectomy Robotic prostatectomy Robot assisted...

... Complication of Anatomical Radical Retropubic Prostatectomy: Lessons from a Single-Center Experience KeyW ords Prostatic carcinoma Prostatectomy Complications, prostatectomy Abstract Objectives: The purpose of this study is to report the rate of early complications in 316 of 600 patients who underwent...

... during surgery or removal of organs for transplantation. The cases analyzed represent normal prostates (n = 4); benign prostatic hyperplasias (n = 10; prostatic carcinomas with Gleason scores of 2-4 (n = 5), 5–7 (n = 10), and 8–10 (n = 3), and prostatic carcinomas treated with hormonal therapy (n = 15...

... months later, cystoscopy showed papillary metastases of the prostatic carcinoma in the bladder. Immunohistochemistry and flow cytometry for various prognostic factors showed a high malignant potential of this tumor. Preoperative transurethral instrumentation for the treatment of urethral strictures may...

...Peter Henriksson; Birgitta Linde Patients with prostatic carcinoma were randomised to treatment with surgical castration (n = 47) or oral oestrogen therapy (n = 53). The oestrogen-treated patients received oral ethinyl oestradiol daily, 1 mg for the first 2 weeks followed by 150 µg. In addition...

...Kenjiro Kohri; Takanori Yamate; Hirononi Tsujihashi; Yuzo Nakao; Yoshikazu Katayama; Yasushi Hara; Yasuyuki Morikawa; Takashi Kurita We describe a 62-year-old male with brain metastasis from prostatic carcinoma, which regressed with medical and surgical endocrine therapies. The patient’s presenting...

...R. Tomić; J.-E. Damber Serum concentrations of testosterone, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) were determined before and after orchidectomy performed at different intervals (2–29 months) after withdrawal of estrogen therapy in patients with prostatic carcinoma...

...Herbert Oelschläger; Dietrich Rothley; Udo Dunzendorfer For more than 30 years Fosfestrol (Honvan®) has been used as an estrogen for successful palliative therapy of prostatic carcinoma, but the pharmacokinetics of this compound were unknown due to the lack of analytical methods. Over the last few...

...Carlos D. Jurincic; Hans U. Pixberg; Alexander Gasser; Karl-Friedrich Klippel To evaluate the clinical and prognostic value of prostate-specific antigen (PSA) for the detection of tumor and tumor growth after therapy, 520 sera from 246 patients with prostatic carcinoma, 990 sera from patients...

.... Prostatic carcinoma Metastases Biopsy Urol Int 1990;45:370-371 ©1990 S. Karger AG. Basel 0042-1138/90/0456-037052.75/0 Perineal Seeding of Prostatic Carcinoma after Trucut Biopsy John Bach, Hanne Gôte, Dennis Raahave Department of Urology, University Hospital, Frederiksberg, Copenhagen, Denmark Key...

...P. Kristiansen; D. Bergqvist; L. Janzon; P. Pompeius Administration of estrogen as a treatment of patients with prostatic carcinoma has been correlated with an increase in the frequency of cardiovascular complications. The purpose of the present autopsy investigation was to study the incidence...

...H. Al-Abadi; R. Nagel The ploidy, DNA heterogeneity and the phases of the cell cycle of the tumor were analyzed, by means of single-cell DNA cytophotometry, in 329 patients with locally advanced prostatic carcinoma to find out and establish prognostic factors apart from those already known (stage...

.... The benefits of DESDP have been ascribed to its specific cytotoxic activity towards prostatic carcinoma cells. To evaluate the tissue specificity of the cytotoxic effect, we exposed three prostatic carcinoma cell lines (LNCaP, DU 145, and PC-3), three non-prostatic neoplastic cell lines (KB: epidermoid...

...D. Hauri; M. Heinzelmann; K. Konstantinidis 14 03 1988 18 03 1988 29 1 2010 Original Papers Urol Int 43: 257-264 (1988) © 1988 S. Karger AG, Basel 0042-1138/88/0435-0257J2.75/0 Radical Prostatectomy in Cases of Prostatic Carcinoma: The Problem of Postoperative Urinary...

...B. Schwemmer; A. Lehmer; R. Hofmann; J. Braun In patients with prostatic carcinoma, natural killer (NK) cell activity was monitored in a chromium release assay. Cells from the human myeloid cell line K 562 and from a human prostatic cancer cell line (PC 3) were used as target cells. Additionally...

..., the measurement of this receptor had a limited value for the purpose of treating the patient with antiandrogenic agents. 3 04 1985 20 04 1985 29 1 2010 Urol. int. 40: 298-300 (1985) © 1985 S. Karger AG, Basel 0042-1138/85/0405-029852.75/0 A Case of Prostatic Carcinoma with Skin Métastasés Eiso...

...B. Helpap The combined histologic and cytologic grading of carcinomas of the prostate is not only important in evaluation of prognosis but determines the choice of therapy with knowledge of staging. Tissue biopsies of 2,200 prostatic carcinomas were classified and graded histologically...

...R. Ackermann; M. Wirth; L. Hasler; T. Okabe In earlier experiments it has been shown that cellular cytotoxicity of patients with prostatic carcinoma (CaP) as measured by cytolysis of EB 33 target cells correlates with the extent of their tumor lesion: a high grade of cytotoxicity was observed only...

... cancer detection Renal cell carcinoma Prostatic carcinoma Urinary tract tumors Urol. int. 37: 1-18 (1982) Erfüllen die urologischen Tumoren die Voraussetzungen für eine sinnvolle Früherkennungsuntersuchung? H. Rübben, F.J. Hering, G. Durben, W. Lutzeyer Abteilung Urologie (Vorstand: Prof. W...

...Tohru Shinkawa; Tetsuro Ohfuji; Yukio Osada; Nobuyuki Ishisawa A clinical study of the adverse effects induced by the endocrine therapy with a high dose of estrogen in 45 patients with stage C or D prostatic carcinoma is conducted. Transient decreases of hemoglobin and serum protein values were...